中文 | English
Return
Total: 2618 , 1/262
Show Home Prev Next End page: GO
Author:( bo, FENG)

1.DPP-4 inhibitors and glucose homeostasis - From cell to bedside

Bo FENG

Chinese Journal of Endocrinology and Metabolism 2012;28(6):525-526

2.Content Determination of Oleanolic Acid and Ursolic Acid in Prunella vulgaris by HPLC

Shuying GUO ; Bo FENG

China Pharmacy 2007;0(27):-

3.Inhibitory effect of 4'-methylether-scutellarein on human choriocarcinoma JAR cells and the possible mechanism

Bo FENG ; Changfen XU

Chinese Journal of Cancer Biotherapy 2006;0(05):-

4.Segmental splenectomy, the first choice for treatment of splenic benign tumor

Bo HUANG ; Bianxi FENG

Chinese Journal of Hepatobiliary Surgery 2010;16(6):410-412

5.13C-octanoic acid breath test for measurement of solid gastric emptying: reproducibility in normal subjects and patients with diabetes mellitus

Bo, FENG ; Ziegler, DAN

Chinese Journal of Nuclear Medicine 2001;21(2):107-108

6.An clinical analysis of gastrointestinal stromal tumors

Huiqin SHEN ; Bo FENG

Chinese Journal of General Surgery 2017;32(7):553-556

7.The influence of continuous quality improvement on nutritional status and renal function and low protein diet adherence in patients with chronic kidney disease

Sue CHEN ; Bo FENG

Journal of Endocrine Surgery 2014;(2):167-169

8.Changes of arterial blood pressure variability and baroreflex sensitivity in diabetic patients

Bo FENG ; Yafang NI

Chinese Journal of Endocrinology and Metabolism 2001;0(05):-

9.Simultaneous Determination of 6 Kinds of Components in Longze Xiongdan Capsules by HPLC

Chengyi HAO ; Bo FENG

China Pharmacy 2017;28(9):1246-1249

10.Liraglutide alleviates arteriosclerotic lesions and inhibits receptor for advanced glycation end-product expression in diabetic ApoE-/- mice

Peicheng LI ; Bo FENG

Chinese Journal of Endocrinology and Metabolism 2016;32(8):680-684

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 2618 , 1/262 Show Home Prev Next End page: GO